Role of skip N2 lymph node metastasis for patients with the stage III-N2 lung adenocarcinoma: a propensity score matching analysis

[1] Siegel RL(2022)Cancer statistics, 2022 CA Cancer J Clin 72 7-33

[2] Miller KD(2015)The International Association for the study of Lung Cancer Lung Cancer Staging Project: proposals for the revision of the N descriptors in the Forthcoming 8th Edition of the TNM classification for Lung Cancer J Thorac Oncol 10 1675-84

[3] Fuchs HE(2021)Application of N descriptors proposed by the International Association for the study of Lung Cancer in Clinical Staging Radiology 300 450-7

[4] Jemal A(2019)Recommended change in the N descriptor proposed by the International Association for the study of Lung Cancer: a validation study J Thorac Oncol 14 1962-9

[5] Asamura H(2019)Comparison between lymph node station- and zone-based classification for the future revision of node descriptors proposed by the International Association for the study of Lung Cancer in surgically resected patients with non-small-cell lung cancer Eur J Cardiothorac Surg 56 849-57

[6] Chansky K(2005)Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis Ann Thorac Surg 79 225-33

[7] Crowley J(2015)The clinicopathological features associated with skip N2 metastases in patients with clinical stage IA non-small-cell lung cancer Eur J Cardiothorac Surg 47 653-8

[8] Song H(2021)New N1/N2 classification and lobe specific lymphatic drainage: impact on survival in patients with non-small cell lung cancer treated with surgery Lung Cancer 151 84-90

[9] Yoon SH(2020)Validation of the proposed cN2 subclassification in the Eighth Edition of the IASLC Staging System: a prospective phase II Multicenter Study JTO Clin Res Rep 1 100019-22

[10] Kim J(2015)Prognostic factors for surgically resected N2 non-small cell Lung Cancer Ann Thorac Cardiovasc Surg 21 217-77

[1] Siegel RL(2022)Cancer statistics, 2022 CA Cancer J Clin 72 7-33

[2] Miller KD(2015)The International Association for the study of Lung Cancer Lung Cancer Staging Project: proposals for the revision of the N descriptors in the Forthcoming 8th Edition of the TNM classification for Lung Cancer J Thorac Oncol 10 1675-84

[3] Fuchs HE(2021)Application of N descriptors proposed by the International Association for the study of Lung Cancer in Clinical Staging Radiology 300 450-7

[4] Jemal A(2019)Recommended change in the N descriptor proposed by the International Association for the study of Lung Cancer: a validation study J Thorac Oncol 14 1962-9

[5] Asamura H(2019)Comparison between lymph node station- and zone-based classification for the future revision of node descriptors proposed by the International Association for the study of Lung Cancer in surgically resected patients with non-small-cell lung cancer Eur J Cardiothorac Surg 56 849-57

[6] Chansky K(2005)Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis Ann Thorac Surg 79 225-33

[7] Crowley J(2015)The clinicopathological features associated with skip N2 metastases in patients with clinical stage IA non-small-cell lung cancer Eur J Cardiothorac Surg 47 653-8

[8] Song H(2021)New N1/N2 classification and lobe specific lymphatic drainage: impact on survival in patients with non-small cell lung cancer treated with surgery Lung Cancer 151 84-90

[9] Yoon SH(2020)Validation of the proposed cN2 subclassification in the Eighth Edition of the IASLC Staging System: a prospective phase II Multicenter Study JTO Clin Res Rep 1 100019-22

[10] Kim J(2015)Prognostic factors for surgically resected N2 non-small cell Lung Cancer Ann Thorac Cardiovasc Surg 21 217-77